Match!
Javier Narváez
Bellvitge University Hospital
220Publications
31H-index
2,757Citations
Publications 222
Newest
Source
Resumen Objetivos Analizar el riesgo de fractura calculado por FRAX® y la frecuencia de alto riesgo de fractura en la poblacion general en Espana. Metodos EPISER2016 es un estudio transversal multicentrico de base poblacional de la prevalencia de las enfermedades reumaticas en poblacion adulta en Espana. Un total de 3.154 sujetos de edad igual o superior a 40 anos (1.184 hombres y 1.970 mujeres) se seleccionaron mediante muestreo aleatorio estratificado. Las preguntas relacionadas con los factor...
Source
#1Javier NarváezH-Index: 31
#2J. LLuchH-Index: 1
Last.Ivan CastellvíH-Index: 14
view all 6 authors...
We read with great interest the results of the double-blind phase 2 faSScinate clinical trial,1 in which there was encouraging (although not statistically significant) numerical improvement in skin thickening and evidence of less decline in lung function in patients with systemic sclerosis (SSc) treated with tocilizumab (TCZ) compared with those receiving placebo. Initial investigations with TCZ in patients with SSc demonstrated improvements in skin sclerosis and polyarthritis.2 3 Scleroderma-as...
1 CitationsSource
#1J. LLuchH-Index: 1
Last.Javier NarváezH-Index: 31
view all 4 authors...
Source
#1T. Cobo-Ibáñez (UEM: European University of Madrid)H-Index: 4
Last.Jose M. Pego-ReigosaH-Index: 10
view all 40 authors...
Source
#1Raimon SanmartíH-Index: 37
#2Jesús Tornero (University of Alcalá)H-Index: 11
Last.Jaime Calvo-AlénH-Index: 30
view all 15 authors...
Abstract Objectives (1) To systematically and critically review the evidence on the characteristics, efficacy and safety of glucocorticoids (CS) in rheumatoid arthritis (RA); (2) to generate practical recommendations. Methods A systematic literature review was performed through a sensitive bibliographic search strategy in Medline, Embase and the Cochrane Library. We selected randomized clinical trials that analyzed the efficacy and/or safety of CS in patients with RA. Two reviewers performed the...
Source
#2Alba Erra (RAFAEL: Rafael Advanced Defense Systems)H-Index: 9
Last.Loreto CarmonaH-Index: 53
view all 17 authors...
With the aim to develop and validate a clinical + ultrasound (US) inflammation score in rheumatoid arthritis (RA) for use in clinical practice, a mixed-method study was conducted. The theoretical development of the index was achieved with qualitative methodology (discussion group and Delphi survey). Subsequently, a cross-sectional study was carried out to analyse issues related to scoring and validation of the new index. RA patients underwent clinical [28 swollen and tender joints count, patient...
Source
Abstract Objective To investigate the prevalence, clinical characteristics and prognosis of pulmonary arterial hypertension (PAH) in adult onset Still's disease (AOSD). Methods We retrospectively reviewed all patients with AOSD diagnosed during a 33-year period in 2 referral tertiary care hospitals, selecting for analysis those who presented PAH confirmed as by right heart catheterization. A systematic review of the literature (PubMed 1990 to July 2018) was also performed, in order to determine ...
Source
#1Monica Calderón-Goercke (UC: University of Cantabria)H-Index: 2
#2Javier Loricera (UC: University of Cantabria)H-Index: 16
Last.Ricardo Blanco (UC: University of Cantabria)H-Index: 37
view all 59 authors...
Abstract Objective: Tocilizumab (TCZ) has shown efficacy in clinical trials on giant cell arteritis (GCA). Real-world data are scarce. Our objective was to assess efficacy and safety of TCZ in unselected patients with GCA in clinical practice Methods: Observational, open-label multicenter study from 40 national referral centers of GCA patients treated with TCZ due to inefficacy or adverse events of previous therapy. Outcomes variables were improvement of clinical features, acute phase reactants,...
5 CitationsSource
Background Giant cell arteritis (GCA) can be refractory to corticosteroid therapy. Tocilizumab (TCZ) has been approved in the treatment of GCA. There are no studies comparing the efficacy and safety when using TCZ as monotherapy or in combination with conventional immunosuppressive drugs in GCA. Objectives Our aim was to compare efficacy and safety of TCZ combined or in monotherapy in GCA. Methods Multicenter study on 134 patients with refractory GCA who received TCZ therapy as monotherapy or co...
Source
12345678910